ClinicalTrials.Veeva

Menu
P

Paradigm Clinical Research Centers, LLC | Redding, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Pirfenidone
Deupirfenidone
Buloxibutid
Ridinilazole
Vancomycin
NOC-110
LYT-100
K-304

Parent organization

This site is a part of Paradigm Clinical Research Centers, LLC

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

7 of 18 total trials

A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

This is a double-blind, randomized, multicenter, outpatient evaluation of the safety and efficacy of elismetrep, as compared with placebo, in the tre...

Not yet enrolling
Migraine
Drug: Placebo
Drug: Elismetrep
Locations recently updated

Approximately one billion cases of seasonal influenza occur annually. Of these, 3 to 5 million illnesses are severe and responsible for up to 650,000...

Active, not recruiting
Influenza
Combination Product: MK-1406
Combination Product: Placebo

The ASPIRE trial is a 52 week randomized, double-blind, placebo-controlled, parallel-group, multicenter trial in which the efficacy, safety, and phar...

Active, not recruiting
Idiopathic Pulmonary Fibrosis (IPF)
Drug: Placebo
Drug: Buloxibutid

The North Star study is a multi-center, Phase 3, open-label, single-arm clinical study to evaluate the Efficacy and Safety of North Star therapy.

Enrolling
Hypothyroidism
Drug: Desiccated Porcine Thyroid Extract Tablets

This study a randomized, double-blind, four arm study to evaluate the safety and efficacy of LYT-100 compared to pirfenidone or placebo in adults wit...

Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: Deupirfenidone
Drug: Placebo

This is a phase 2b, randomized, double-blind, placebo-controlled study investigating the efficacy, safety, and tolerability of Taplucainium Inhalatio...

Active, not recruiting
Refractory or Unexplained Chronic Cough
Drug: NOC-110
Other: Placebo

This is a study for adults with a lung disease called idiopathic pulmonary fibrosis. The main purpose of this study is to look at how well deupirfeni...

Enrolling
Idiopathic Pulmonary Fibrosis (IPF)
Drug: Deupirfenidone
Drug: Pirfenidone (PFD)

Trial sponsors

Pfizer logo
Janssen (J&J Innovative Medicine) logo
P
BioNTech logo
K
Merck Sharp & Dohme (MSD) logo
N
N
Seqirus logo
Summit Therapeutics logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems